家庭与学校联合哮喘教育项目对Head Start哮喘儿童的有效性:一项随机临床试验
该随机临床试验纳入398名巴尔的摩Head Start学前项目哮喘儿童,比较家庭哮喘基础教育(ABC)联合Head Start哮喘教育与单纯Head Start哮喘教育的效果。结果显示联合干预在12个月内改善了哮喘控制(TRACK评分β=6.26,95%CI 1.77-10.75,P<.001),减少口服糖皮质激素疗程(β=-0.61,95%CI -1.13至-0.09,P=.02)并降低住院风险(OR=0.36,95%CI 0.21-0.61,P<.001)。
要点
- 家庭联合学校哮喘教育可改善低收入少数族裔学龄前儿童哮喘控制。
- 联合干预减少口服糖皮质激素疗程和住院风险。
- 在多层级社区环境实施教育干预可能有助于减少哮喘结局差异。
核心结论
- 家庭与学前机构联合哮喘教育干预可改善哮喘控制、减少口服糖皮质激素疗程并降低住院风险。
研究设计与样本
- 随机临床试验纳入398名巴尔的摩Head Start学前项目哮喘儿童及其主要照护者,比较ABC家庭联合Head Start哮喘教育与单纯Head Start哮喘教育。
主要发现
- ABC联合Head Start项目改善哮喘控制(β=6.26;95%CI 1.77至10.75;P<.001)。
- 联合干预减少口服糖皮质激素疗程(β=-0.61;95%CI -1.13至-0.09;P=.02)。
- 联合干预降低12个月内住院风险(OR=0.36;95%CI 0.21-0.61;P<.001)。
关键数值与推荐
- 哮喘控制以TRACK评分评估。
- 分析纳入398名儿童(247名男孩[62.1%];平均[SD]年龄4.2[0.7]岁)。
临床怎么用
- 在服务低收入少数族裔家庭的社区环境中,可考虑实施家庭与学前机构联合哮喘教育干预以改善哮喘结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Asthma is the most common chronic childhood disease, with Black children experiencing worse morbidity and mortality. It is important to evaluate the effectiveness of efficacious interventions in community settings that have the greatest likelihood of serving at-risk families. OBJECTIVE: To evaluate the effectiveness of a multilevel home- and school (Head Start)-based asthma educational program compared with a Head Start-based asthma educational program alone in improving asthma outcomes in children. DESIGN, SETTING, AND PARTICIPANT: This randomized clinical trial included 398 children with asthma enrolled in Head Start preschool programs in Baltimore, Maryland, and their primary caregivers. Participants were recruited from April 1, 2011, to November 31, 2016, with final data collection ending December 31, 2017. Data were analyzed from March 18 to August 30, 2018. INTERVENTIONS: Asthma Basic Care (ABC) family education combined with Head Start asthma education compared with Head Start asthma education alone. MAIN OUTCOMES AND MEASURES: Asthma control as measured by the Test for Respiratory and Asthma Control in Kids (TRACK) score. RESULTS: Among the 398 children included in the analysis (247 boys [62.1%]; mean [SD] age, 4.2 [0.7] years), the ABC plus Head Start program improved asthma control (β = 6.26; 95% CI, 1.77 to 10.75; P < .001), reduced courses of oral corticosteroids (β = -0.61; 95% CI, -1.13 to -0.09; P = .02), and reduced hospitalizations (odds ratio, 0.36; 95% CI, 0.21-0.61; P < .001) during a 12-month period. CONCLUSION AND RELEVANCE: In this randomized clinical trial, combined family and preschool asthma educational interventions improved asthma control and reduced courses of oral corticosteroids and hospitalizations. Multilevel interventions implemented in community settings that serve low-income minority families may be key to reducing disparities in asthma outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01519453.
引用
- Eakin MN, Zaeh S, Eckmann T, et al. Effectiveness of a Home- and School-Based Asthma Educational Program for Head Start Children With Asthma: A Randomized Clinical Trial. JAMA Pediatr. 2020. PMID: 33016987. doi:10.1001/jamapediatrics.2020.3375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。